Expedite™ Therapeutic Nutrional Drink for Wound Healing Key Research
Dipeptides Research
Citation |
Study Design |
Patient Population |
Groups |
Outcomes |
---|---|---|---|---|
Jimi S, Koizumi S, Sato K, Miyazaki M, Saparov A. Collagen-derived dipeptide Pro-Hype administration accelerates muscle regenerative healing accompanied by less scarring after wounding on the abdominal wall in mice. Sci Rep.2021;11(1):18750. doi:10.1038/s41598-021-98407-9. |
Clinical trial; free drinking for 21 days |
Mice with abdominal surgery |
|
Pro-Hyp administration accelerated muscle regenerative healing, accompanied by less scarring, after wounding of the abdominal wall. Pro-Hyp could be administered to patients with pressure injuries, who have undergone surgery or have trauma to help activate the wound-healing process. |
Lee SK, Posthauer ME, Dorner B, Redovian V, Maloney MJ. Pressureulcer healing with a concentrated, fortified, collagen protein hydrolysate supplement: a randomized controlled trial. Adv Skin Wound Care. 2006;19(2): 92-96. doi:10.1097/00129334-200603000-00011. |
Randomized trial for 8 weeks at 23 longterm care facilities in four states |
89 residents with stage 2, 3, or 4 pressure injuries; 71 completed the study |
|
Residents who received standard care plus the concentrated, fortified, collagen protein hydrolysate supplement had significantly better PUSH tool scores compared to those who had standard care plus placebo. |
Sato K, Asai TT, Jimi S. Collagen-derived di-peptide, prolylhydroxyproline (Pro-Hyp): a new low molecular weight growth-initiating factor for specific fibroblasts associated with wound healing. Front Cell Dev Biol. 2020;8:543975. doi:10.3389/fcell.2020.548975. |
Review |
Animal studies and human clinical trials |
|
Ingestion of collagen hydrolysate enhances wound healing, especially diabetes-induced chronic wounds and pressure injuries. Pro-Hyp is a low molecular weight growth-initiating factor for specific fibroblasts that are involved in the wound healing process. |
Skov K, Oxfeldt M, Thögersen R, Hansen M, Bertram HC. Enzymatic hydrolysis of a collagen hydrolysate enhances postprandial absorption rate—a randomized controlled trial. Nutrients. 2019;11(5):1064. doi:10.3390/nu11051064. |
Randomized, blinded, cross-over trial |
Ten healthy males, ages 18-35 years |
|
Enzymatic hydrolysis of collagen is associated with enhanced absorption of glycine, proline, and hydroxyproline 20 minutes post-ingestion. Also, a greater AUC for glycine, proline, and hydroxyproline for an EHC hydrolysate suggested a higher bioavailability for EHC compared to a nonenzymatically hydrolyzed collagen hydrolysate. |
Sugihara F, Inoue N, Venkateswarathirukumara S. Ingestion of bioactive collagen hydrolysates enhanced pressure ulcer healing in a randomized double-blind placebo-controlled clinical study. Sci Rep. 2018;8(1):11403. doi:10.1038/s41598-018-29831-7. |
Double-blind, placebo controlled clinical study |
Subjects with pressure injuries, stage II or III; 112 subjects completed the study |
|
Collagen hydrolysate with higher levels of Pro-Hyp and Hyp-Gly helps heal pressure injuries as measured by improvement in PUSH and PSST scores. |
AUC=area under the curve, EHC=enzymatically hydrolyzed collagen hydrolysate, IV=intravenous, Pro-Hyp=prolylhydroxyproline,
Hyp-Gly=hydroxyprolylglycine, NO=nitric oxide, PUSH=Pressure Ulcer Scale for Healing, PSST=Pressure Sore Status Tool